BridgeMD
New treatment option for Infertility (IVF Patients)
Official title The Role of hCG in Thawed Embryo Transfer
ClinicalTrials.gov ID: NCT07004192
What this study is testing
What is HCG injection?
HCG injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for infertility (ivf patients).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Female adult expecting to receive transfer of a thawed embryo.
- At least one available frozen blastocyst of transferrable quality.
- Non-menopausal female with at least one antral follicle.
- Use of pre-implantation genetic testing (PGT), embryos derived from donor oocytes and/or donor sperm, a gestational carrier, and history of prior...
- Subsequent embryo transfers after failed transfers under this study are allowed, but not after a transfer that has resulted in ongoing pregnancy at...
You likely can't join if
- Minors (age\<18 years).
- Use of embryo(s) frozen at another center.
- Patient insistent on transfer of two embryos.
- Patient or partner unable to provide informed consent in English.
- Patient already enrolled in any other research study for her embryo transfer.
- History of anti-phospholipid syndrome or any other indication for use of Lovenox in pregnancy.
See the full eligibility criteria
- Female adult expecting to receive transfer of a thawed embryo.
- At least one available frozen blastocyst of transferrable quality.
- Non-menopausal female with at least one antral follicle.
- Use of pre-implantation genetic testing (PGT), embryos derived from donor oocytes and/or donor sperm, a gestational carrier, and history of prior transfer(s) regardless of outcome are allowed.
- Subsequent embryo transfers after failed transfers under this study are allowed, but not after a transfer that has resulted in ongoing pregnancy at ten weeks gestation under this study.
- Minors (age\<18 years).
- Use of embryo(s) frozen at another center.
- Patient insistent on transfer of two embryos.
- Patient or partner unable to provide informed consent in English.
- Patient already enrolled in any other research study for her embryo transfer.
- History of anti-phospholipid syndrome or any other indication for use of Lovenox in pregnancy.
- Patient for whom the physician assesses this protocol is inappropriate or unsafe.
The study team makes the final eligibility decision.
Where it's taking place
- Las Vegas, Nevada, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Las Vegas, Nevada, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.